Interleukin-2 enhances the natural killer cell response to Herceptin-coated Her2/neu-positive breast cancer cells. [electronic resource]
Producer: 20011204Description: 3016-25 p. digitalISSN:- 0014-2980
- Animals
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antibody-Dependent Cell Cytotoxicity
- Breast Neoplasms -- immunology
- CD56 Antigen -- analysis
- Cytokines -- biosynthesis
- Humans
- Interleukin-2 -- pharmacology
- Killer Cells, Natural -- drug effects
- Lymphocyte Activation
- Mice
- Receptor, ErbB-2 -- analysis
- Receptors, IgG -- physiology
- Trastuzumab
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.